Cargando…
Serum Dickkopf-1 in Combined with CA 19-9 as a Biomarker of Intrahepatic Cholangiocarcinoma
SIMPLE SUMMARY: Cholangiocarcinoma (CCC) is a rare cancer, but its incidence and mortality have been increased in the past few decades worldwide, representing a global health problem. CCC is usually asymptomatic in early stages and, therefore, often diagnosed when the disease is already in advanced...
Autores principales: | Kim, Si-Young, Lee, Hee-Seung, Bang, Seung-Min, Han, Dai-Hoon, Hwang, Ho-Kyoung, Choi, Gi-Hong, Chung, Moon-Jae, Kim, Seung-Up |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069292/ https://www.ncbi.nlm.nih.gov/pubmed/33921232 http://dx.doi.org/10.3390/cancers13081828 |
Ejemplares similares
-
Postoperative CA19-9 Change Is a Useful Predictor of Intrahepatic Cholangiocarcinoma Survival following Liver Resection
por: Yoo, Tae, et al.
Publicado: (2015) -
Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma
por: Kim, Seung Up, et al.
Publicado: (2015) -
Serum Markers of Intrahepatic Cholangiocarcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2013) -
Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping
por: Lee, Hee Seung, et al.
Publicado: (2023) -
Dickkopf-1 induces angiogenesis via VEGF receptor 2 regulation independent of the Wnt signaling pathway
por: Choi, Sung Hoon, et al.
Publicado: (2017)